Milestone Pharmaceuticals (MIST) PT Lowered to $17 at Oppenheimer
Tweet
Share
E-mailGet Alerts MIST Hot Sheet
Price: $1.10 +2.80%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell lowered the price target on Milestone Pharmaceuticals (NASDAQ: MIST) to $17.00 (from $18.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Milestone Pharmaceuticals Inc. (MIST) Misses Q2 EPS by 2c
- Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
